Skip to main content
NCBI home page
Infection and Immunity logoLink to Infection and Immunity
. 1983 Jun;40(3):950–955. doi: 10.1128/iai.40.3.950-955.1983

Influence of preformed antibody on the pathogenesis of experimental Candida albicans endocarditis.

W M Scheld, R A Calderone, J P Brodeur, M A Sande
PMCID: PMC348144  PMID: 6343246

Abstract

The influence of preformed antibody on the induction of experimental Candida albicans endocarditis was investigated by both in vitro and in vivo techniques. Preincubation of C. albicans with immune serum (raised in rabbits by intravenous injection of Formalin-killed yeast cells) decreased adhesion to the constituents of nonbacterial thrombotic endocarditis, e.g., fibrin plus platelets, in vitro. Two different methods, with radiolabeled or viable yeast cells, were confirmatory and demonstrated decreased adhesion of immune serum-treated C. albicans cells to 0 to 7.8% of control values (P less than 0.001). These results correlated with protection from the development of C. albicans endocarditis in the immunized rabbits. The mean (+/- standard deviation) infectious dose for 50% of the animals was 10(5.29) +/- 10(0.07) in 48 control animals versus 10(7.11) +/- 10(0.22) in 37 immunized rabbits (P less than 0.001). These studies suggest that humoral antibody may protect against C. albicans endocarditis, perhaps through inhibition of adhesion, a crucial early step in the pathogenesis of endocarditis.

Full text

PDF
950

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. ANDRIOLE V. T., KRAVETZ H. M., ROBERTS W. C., UTZ J. P. Candida endocarditis. Clinical and pathologic studies. Am J Med. 1962 Feb;32:251–285. doi: 10.1016/0002-9343(62)90294-2. [DOI] [PubMed] [Google Scholar]
  2. Adler S. W., 2nd, Selinger D. S., Reed W. P. Effect of immunization on the genesis of pneumococcal endocarditis in rabbits. Infect Immun. 1981 Oct;34(1):55–61. doi: 10.1128/iai.34.1.55-61.1981. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Al-Doory Y., Paasch L. H., Zook B. C., Rhorer R. G. Pathological studies in experimental Candida endocarditis. Jpn Heart J. 1979 Jul;20(4):427–440. doi: 10.1536/ihj.20.427. [DOI] [PubMed] [Google Scholar]
  4. Araj G. F., Hopfer R. L., Chesnut S., Fainstein V., Bodey G. P., Sr Diagnostic value of the enzyme-linked immunosorbent assay for detection of Candida albicans cytoplasmic antigen in sera of cancer patients. J Clin Microbiol. 1982 Jul;16(1):46–52. doi: 10.1128/jcm.16.1.46-52.1982. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Archer G. L., Johnston J. L. Effect of type-specific active immunization on the development and progression of experimental Pseudomonas aeruginosa endocarditis. Infect Immun. 1979 Apr;24(1):167–173. doi: 10.1128/iai.24.1.167-173.1979. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Bacon P. A., Davidson C., Smith B. Antibodies to candida and autoantibodies in sub-acute bacterial endocarditis. Q J Med. 1974 Oct;43(172):537–550. [PubMed] [Google Scholar]
  7. Calderone R. A., Rotondo M. F., Sande M. A. Candida albicans endocarditis: ultrastructural studies of vegetation formation. Infect Immun. 1978 Apr;20(1):279–289. doi: 10.1128/iai.20.1.279-289.1978. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Durack D. T., Gilliland B. C., Petersdorf R. G. Effect of immunization on susceptibility to experimental Streptococcus mutans and Streptococcus sanguis endocarditis. Infect Immun. 1978 Oct;22(1):52–56. doi: 10.1128/iai.22.1.52-56.1978. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Edwards J. E., Jr, Lehrer R. I., Stiehm E. R., Fischer T. J., Young L. S. Severe candidal infections: clinical perspective, immune defense mechanisms, and current concepts of therapy. Ann Intern Med. 1978 Jul;89(1):91–106. doi: 10.7326/0003-4819-89-1-91. [DOI] [PubMed] [Google Scholar]
  10. Ellsworth J. H., Reiss E., Bradley R. L., Chmel H., Armstrong D. Comparative serological and cutaneous reactivity of candidal cytoplasmic proteins and mannan separated by affinity for concanavalin A. J Clin Microbiol. 1977 Jan;5(1):91–99. doi: 10.1128/jcm.5.1.91-99.1977. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Fraser-Smith E. B., Matthews T. R. Protective effect of muramyl dipeptide analogs against infections of Pseudomonas aeruginosa or Candida albicans in mice. Infect Immun. 1981 Dec;34(3):676–683. doi: 10.1128/iai.34.3.676-683.1981. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Fraser-Smith E. B., Waters R. V., Matthews T. R. Correlation between in vivo anti-Pseudomonas and anti-Candida activities and clearance of carbon by the reticuloendothelial system for various muramyl dipeptide analogs, using normal and immunosuppressed mice. Infect Immun. 1982 Jan;35(1):105–110. doi: 10.1128/iai.35.1.105-110.1982. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Freedman L. R., Johnson M. L. Experimental endocarditis. IV. Tricuspid and aortic valve infection with Candida albicans in rabbits. Yale J Biol Med. 1972 Apr;45(2):163–175. [PMC free article] [PubMed] [Google Scholar]
  14. HASENCLEVER H. F., MITCHELL W. O. ACQUIRED IMMUNITY TO CANDIDIASIS IN MICE. J Bacteriol. 1963 Sep;86:401–406. doi: 10.1128/jb.86.3.401-406.1963. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Jones J. M. Kinetics of antibody responses to cell wall mannan and a major cytoplasmic antigen of Candida albicans in rabbits and humans. J Lab Clin Med. 1980 Nov;96(5):845–860. [PubMed] [Google Scholar]
  16. Levy R., Segal E., Eylan E. Protective immunity against murine candidiasis elicited by Candida albicans ribosomal fractions. Infect Immun. 1981 Mar;31(3):874–878. doi: 10.1128/iai.31.3.874-878.1981. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. MOURAD S., FRIEDMAN L. Active immunization of mice against Candida albicans. Proc Soc Exp Biol Med. 1961 Mar;106:570–572. doi: 10.3181/00379727-106-26405. [DOI] [PubMed] [Google Scholar]
  18. Maisch P. A., Calderone R. A. Adherence of Candida albicans to a fibrin-platelet matrix formed in vitro. Infect Immun. 1980 Feb;27(2):650–656. doi: 10.1128/iai.27.2.650-656.1980. [DOI] [PMC free article] [PubMed] [Google Scholar]
  19. Maisch P. A., Calderone R. A. Role of surface mannan in the adherence of Candida albicans to fibrin-platelet clots formed in vitro. Infect Immun. 1981 Apr;32(1):92–97. doi: 10.1128/iai.32.1.92-97.1981. [DOI] [PMC free article] [PubMed] [Google Scholar]
  20. Manning M., Mitchell T. G. Analysis of cytoplasmic antigens of the yeast and mycelial phases of Candida albicans by two-dimensional electrophoresis. Infect Immun. 1980 Nov;30(2):484–495. doi: 10.1128/iai.30.2.484-495.1980. [DOI] [PMC free article] [PubMed] [Google Scholar]
  21. Meddens M. J., Thompson J., Eulderink F., Bauer W. C., Mattie H., van Furth R. Role of granulocytes in experimental Streptococcus sanguis endocarditis. Infect Immun. 1982 Apr;36(1):325–332. doi: 10.1128/iai.36.1.325-332.1982. [DOI] [PMC free article] [PubMed] [Google Scholar]
  22. Miller J. K. Meningococcal Endocarditis in Immunized Horses. Am J Pathol. 1944 Mar;20(2):269–276. [PMC free article] [PubMed] [Google Scholar]
  23. Oblack D. L., Holder I. A. Active immunisation of mice against muscle damage mediated by Candida albicans. J Med Microbiol. 1979 Nov;12(4):503–506. doi: 10.1099/00222615-12-4-503. [DOI] [PubMed] [Google Scholar]
  24. Phair J. P., Clarke J. Immunology of infective endocarditis. Prog Cardiovasc Dis. 1979 Nov-Dec;22(3):137–144. doi: 10.1016/0033-0620(79)90019-7. [DOI] [PubMed] [Google Scholar]
  25. Rogers T. J., Balish E. Immunity to Candida albicans. Microbiol Rev. 1980 Dec;44(4):660–682. doi: 10.1128/mr.44.4.660-682.1980. [DOI] [PMC free article] [PubMed] [Google Scholar]
  26. Rubinstein E., Noriega E. R., Simberkoff M. S., Holzman R., Rahal J. J., Jr Fungal endocarditis: analysis of 24 cases and review of the literature. Medicine (Baltimore) 1975 Jul;54(4):331–334. [PubMed] [Google Scholar]
  27. Rudd R. M., Hill P. R., Kopelman P., Parker D. J. Fungal endocarditis after homograft valve replacement: difficulties in diagnosis and treatment. Thorax. 1980 Sep;35(9):686–689. doi: 10.1136/thx.35.9.686. [DOI] [PMC free article] [PubMed] [Google Scholar]
  28. Sande M. A., Bowman C. R., Calderone R. A. Experimental Candida albicans endocarditis: characterization of the disease and response to therapy. Infect Immun. 1977 Jul;17(1):140–147. doi: 10.1128/iai.17.1.140-147.1977. [DOI] [PMC free article] [PubMed] [Google Scholar]
  29. Sawyer R. T., Moon R. J., Beneke E. S. Hepatic clearance of Candida albicans in rats. Infect Immun. 1976 Dec;14(6):1348–1355. doi: 10.1128/iai.14.6.1348-1355.1976. [DOI] [PMC free article] [PubMed] [Google Scholar]
  30. Scheld W. M., Calderone R. A., Alliegro G. M., Sande M. A. Yeast adherence in the pathogenesis of Candida endocarditis. Proc Soc Exp Biol Med. 1981 Nov;168(2):208–213. doi: 10.3181/00379727-168-41261. [DOI] [PubMed] [Google Scholar]
  31. Scheld W. M., Thomas J. H., Sande M. A. Influence of preformed antibody on experimental Streptococcus sanguis endocarditis. Infect Immun. 1979 Sep;25(3):781–785. doi: 10.1128/iai.25.3.781-785.1979. [DOI] [PMC free article] [PubMed] [Google Scholar]
  32. Scheld W. M., Valone J. A., Sande M. A. Bacterial adherence in the pathogenesis of endocarditis. Interaction of bacterial dextran, platelets, and fibrin. J Clin Invest. 1978 May;61(5):1394–1404. doi: 10.1172/JCI109057. [DOI] [PMC free article] [PubMed] [Google Scholar]
  33. Seelig M. S., Speth C. P., Kozinn P. J., Toni E. F., Taschdjian C. L. Candida endocarditis after cardiac surgery. Clues to earlier detection. J Thorac Cardiovasc Surg. 1973 Apr;65(4):583–601. [PubMed] [Google Scholar]
  34. Segal E., Sandovsky-Losica H. Experimental vaccination with Candida albicans ribosomes in cyclophosphamide-treated animals. Sabouraudia. 1981 Dec;19(4):267–273. [PubMed] [Google Scholar]
  35. Soles P., Lim L. Y., Louria D. B. Active immunity in experimental candidiasis in mice. Sabouraudia. 1967 Jun;5(4):315–322. doi: 10.1080/00362176785190581. [DOI] [PubMed] [Google Scholar]
  36. Syverson R. E., Buckley H. R., Campbell C. C. Cytoplasmic antigens unique to the mycelial or yeast phase of Candida albicans. Infect Immun. 1975 Nov;12(5):1184–1188. doi: 10.1128/iai.12.5.1184-1188.1975. [DOI] [PMC free article] [PubMed] [Google Scholar]
  37. Thörig L., Thompson J., van Furth R. Effects of immunization and anticoagulation on the development of experimental Escherichia coli endocarditis. Infect Immun. 1980 May;28(2):325–330. doi: 10.1128/iai.28.2.325-330.1980. [DOI] [PMC free article] [PubMed] [Google Scholar]
  38. WINNER H. I. A study of Candida albicans agglutinins in human sera. J Hyg (Lond) 1955 Dec;53(4):509–512. doi: 10.1017/s0022172400001005. [DOI] [PMC free article] [PubMed] [Google Scholar]
  39. Walsh T. J., Hutchins G. M. Postoperative Candida infections of the heart in children: clinicopathologic study of a continuing problem of diagnosis and therapy. J Pediatr Surg. 1980 Jun;15(3):325–331. doi: 10.1016/s0022-3468(80)80148-5. [DOI] [PubMed] [Google Scholar]
  40. Weinstein L., Schlesinger J. J. Pathoanatomic, pathophysiologic and clinical correlations in endocarditis (first of two parts). N Engl J Med. 1974 Oct 17;291(16):832–837. doi: 10.1056/NEJM197410172911609. [DOI] [PubMed] [Google Scholar]

Articles from Infection and Immunity are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES